IGF2AS antibody (AA 101-168) (Biotin)

Catalog No. ABIN1700044

Product Details anti-IGF2AS Antibody (Biotin)

Target: IGF2AS (IGF2-AS) (IGF2 Antisense RNA (IGF2-AS))

Binding Specificity: AA 101-168

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This IGF2AS antibody is conjugated to Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Predicted Reactivity: Human

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human IGF2AS

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for IGF2AS

Target: IGF2AS (IGF2-AS) (IGF2 Antisense RNA (IGF2-AS))

Alternative Name: IGF2AS (IGF2-AS Products)

Synonyms: IGF2-AS1 antibody, IGF2AS antibody, PEG8 antibody, IGF2 antisense RNA antibody, IGF2-AS antibody

Background:

Synonyms: IGF2 Antisense Gene Protein 1, IGF2 Antisense RNA Non-Protein Coding, IGF2 Antisense RNA 1, IGF2 Antisense RNA, IGF2 AS1, IGF2AS, Insulin Like Growth Factor 2, Antisense, PEG8, IG2AS_HUMAN, PEG8/IGF2AS Protein, Putative Insulin-Like Growth Factor 2 Antisense Gene Protein 1.

Background: This gene expresses a paternally imprinted antisense transcript of the insulin-like growth factor 2 gene. The transcript is overexpressed in Wilms' tumor. This gene is predicted to be non-coding because the predicted protein is not conserved in any other species and the majority of transcripts would be candidates for non-sense mediated decay (NMD) if a protein were expressed. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]